Engineered probiotic heads to human trials
Reported byMedicalXpress ↗·Sourced by Goodlede
UBC Okanagan bioengineered probiotic designed to thrive in inflamed gut is entering human clinical trials in Australia this summer after a decade of development for inflammatory bowel disease treatment.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at MedicalXpress
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede